2025
SJR Q3
JCR Q3 · 2,1
30 matched articles
SCIE
Journal detail
Journal of Neuro-Ophthalmology
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1070802215365166
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,409
- Quartile Q3
- H-Index 80
- Cites/doc 0,67
- Docs (3y) 869
- Cites (3y) 675
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,1
- 5Y JIF 2,2
- JCI 0,65
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q3
- Neurology (clinical) Q3
- Ophthalmology Q3
Areas
- Medicine
WoS categories
- Clinical Neurology | Ophthalmology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,409 | 2,1 | 2,2 | 0,65 | Q3 | 80 |
| 2024 | Q3 | Q2 | 0,433 | 2 | 2,5 | 0,64 | Q3 | 74 |
| 2023 | Q2 | Q2 | 0,566 | 2,2 | 2,6 | 0,71 | Q2 | 74 |
| 2022 | Q2 | Q2 | 0,468 | 3,2 | 3,4 | 0,8 | Q2 | 74 |
| 2021 | Q2 | Q1 | 0,731 | 4,4 | 3,8 | 0,89 | Q2 | 74 |
| 2020 | Q2 | Q2 | 0,586 | 3 | 2,9 | 0,89 | Q2 | 74 |
| 2019 | Q2 | Q2 | 0,586 | 2,5 | 2,1 | 0,8 | Q2 | 74 |
| 2018 | — | Q2 | — | 2,5 | 2,4 | 0,78 | Q2 | — |
| 2017 | Q2 | Q2 | 0,605 | 2,2 | 2,3 | 0,66 | Q2 | 74 |
| 2016 | Q2 | Q2 | 0,745 | 2 | 2,1 | — | — | 74 |
| 2015 | Q2 | Q3 | 0,611 | 1,6 | 1,6 | — | — | 74 |
| 2014 | Q2 | Q2 | 0,794 | 1,9 | 1,8 | — | — | 74 |
| 2013 | Q2 | Q2 | 0,548 | 1,8 | 1,5 | — | — | 74 |
| 2012 | Q2 | Q2 | 0,476 | 1,6 | 1,5 | — | — | 74 |
| 2011 | Q2 | Q3 | 0,464 | 1,4 | 1,4 | — | — | 74 |
| 2010 | Q2 | Q3 | 0,408 | 1,1 | 1,3 | — | — | 74 |
| 2009 | — | Q3 | — | 1,1 | 1,5 | — | — | — |
| 2008 | — | Q3 | — | 1,3 | 1,6 | — | — | — |
| 2007 | — | Q2 | — | 1,5 | 1,3 | — | — | — |
| 2006 | — | Q3 | — | 1,1 | — | — | — | — |
| 2005 | — | Q3 | — | 1,1 | — | — | — | — |
| 2004 | — | Q3 | — | 0,9 | — | — | — | — |
| 2003 | — | Q3 | — | 1 | — | — | — | — |
| 2002 | — | Q3 | — | 0,8 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
| 2000 | — | Q4 | — | 0,3 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q4 | — | 0,3 | — | — | — | — |
| 1997 | — | Q3 | — | 0,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 186/296 |
| 2025 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 51/98 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 178/286 |
| 2024 | OPHTHALMOLOGY | SCIE | Q2 | Q3 | 44/99 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 156/280 |
| 2023 | OPHTHALMOLOGY | SCIE | Q2 | Q3 | 34/95 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 101/212 |
| 2022 | OPHTHALMOLOGY | SCIE | Q2 | Q2 | 21/62 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 75/212 |
| 2021 | OPHTHALMOLOGY | SCIE | Q1 | Q2 | 13/62 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 118/208 |
| 2020 | OPHTHALMOLOGY | SCIE | Q2 | Q2 | 27/62 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 106/204 |
| 2019 | OPHTHALMOLOGY | SCIE | Q2 | Q2 | 21/60 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 107/199 |
| 2018 | OPHTHALMOLOGY | SCIE | Q2 | Q2 | 19/60 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 124/197 |
| 2017 | OPHTHALMOLOGY | SCIE | Q2 | Q2 | 26/59 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 125/194 |
| 2016 | OPHTHALMOLOGY | SCIE | Q2 | — | 27/59 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 141/193 |
| 2015 | OPHTHALMOLOGY | SCIE | Q3 | — | 30/56 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 117/192 |
| 2014 | OPHTHALMOLOGY | SCIE | Q2 | — | 25/57 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 118/194 |
| 2013 | OPHTHALMOLOGY | SCIE | Q2 | — | 28/58 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 123/193 |
| 2012 | OPHTHALMOLOGY | SCIE | Q2 | — | 27/59 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 140/192 |
| 2011 | OPHTHALMOLOGY | SCIE | Q3 | — | 31/58 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 147/185 |
| 2010 | OPHTHALMOLOGY | SCIE | Q3 | — | 36/56 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 130/167 |
| 2009 | OPHTHALMOLOGY | SCIE | Q3 | — | 35/49 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 117/156 |
| 2008 | OPHTHALMOLOGY | SCIE | Q3 | — | 30/48 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 92/146 |
| 2007 | OPHTHALMOLOGY | SCIE | Q2 | — | 22/45 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 105/147 |
| 2006 | OPHTHALMOLOGY | SCIE | Q3 | — | 28/45 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 97/148 |
| 2005 | OPHTHALMOLOGY | SCIE | Q3 | — | 26/44 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 113/140 |
| 2004 | OPHTHALMOLOGY | SCIE | Q3 | — | 27/42 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 95/135 |
| 2003 | OPHTHALMOLOGY | SCIE | Q3 | — | 26/41 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 99/138 |
| 2002 | OPHTHALMOLOGY | SCIE | Q3 | — | 26/41 |
| 2001 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 96/136 |
| 2001 | OPHTHALMOLOGY | SCIE | Q3 | — | 28/43 |
| 2000 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 125/137 |
| 2000 | OPHTHALMOLOGY | SCIE | Q4 | — | 38/41 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 112/132 |
| 1999 | OPHTHALMOLOGY | SCIE | Q4 | — | 35/43 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 116/125 |
| 1998 | OPHTHALMOLOGY | SCIE | Q4 | — | 39/42 |
| 1997 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 93/107 |
| 1997 | OPHTHALMOLOGY | SCIE | Q3 | — | 27/39 |